https://www.selleckchem.com/products/ml351.html
upplemental material is available for this article. See also the editorial by Jacobson and Van den Abbeele in this issue.Background Improving diagnosis of ductal carcinoma in situ (DCIS) before surgery is important in choosing optimal patient management strategies. However, patients may harbor occult invasive disease not detected until definitive surgery. Purpose To assess the performance and clinical utility of mammographic radiomic features in the prediction of occult invasive cancer among women diagnosed with DCIS on the basis of core